首页 | 本学科首页   官方微博 | 高级检索  
     检索      

Th17细胞相关细胞因子与急性移植物抗宿主病关系的探讨
引用本文:凌艳英,;周铭,;王阿慧,;江雪杰,;李庆山.Th17细胞相关细胞因子与急性移植物抗宿主病关系的探讨[J].江汉大学学报(自然科学版),2014(4):63-68.
作者姓名:凌艳英  ;周铭  ;王阿慧  ;江雪杰  ;李庆山
作者单位:[1]广州医科大学附属广州市第一人民医院检验科血液室; [2]广州医科大学附属广州市第一人民医院血液科,广东广州510180; [3]南方医科大学附属南方医院血液,科广东广州510515
基金项目:广东省自然科学基金资助项目(S2013010016726)
摘    要:目的探讨异基因造血干细胞移植治疗血液系统疾病后,血清中Th17细胞相关的细胞因子与急性移植物抗宿主病的关系。方法 78例血液病患者进行异基因造血干细胞移植,对移植后发生急性移植物抗宿主病患者(n=12),未发生急性移植物抗宿主病患者(n=14),及健康对照组(n=10),以及发生急性移植抗宿主病患者(n=10)在有效治疗前后,采用酶联免疫吸附法检测血清中细胞因子IL-17、IL-23、IL-21、IFN-γ、TGF-β1、IL-22浓度。结果 1 aGVHD者(n=12)血清中Th17细胞相关因子浓度(pg/mL)较正常对照组(n=10)和无aGVHD组(n=14)显著增高,差异有统计学意义(P<0.05);而TGF-β1(1 156.61±458.04)显著低于正常对照组(2 978.34±1 647.71)和无aGVHD组(2 541.62±1 805.16),差异有统计学意义(P<0.05)。IL-22:未发生aGVHD组高于健康对照组(22.14±2.49,19.18±1.24),差异有统计学意义(P<0.05);除IL-21、IL-22和IL-23浓度高于健康对照组外(P<0.05),其余的细胞因子健康对照组和无急性aGVHD组差异无统计学意义(P>0.05),aGVHD组血清IL-22浓度与无aGVHD和健康对照组比较,差异无统计学意义(P>0.05)。210例有效治疗者,治疗后均有降低,治疗前后差异有统计学意义(P<0.05),而IL-22在有效治疗前后差异无统计学意义(P>0.05)。结论 Th17细胞相关的细胞因子与(IL-17、IL-23、IL-21、IFN-γ、TGF-β1)与aGVHD的发生发展和疗效有关,而与IL-22无关。

关 键 词:移植物抗宿主病  急性  细胞因子  Th17细胞  调节性T细胞

Relationship of Cytokines Associated with Th17 Cells and Acute Graft-versus-host Disease
Institution:LING Yanying, ZHOU Ming, WANG Ahui, JIANG Xuejie, LI Qingshan (1.a. Clinical Laboratory, b. Department of Hematology, Guangzhou First People' s Hospital, Guangzhou Medical University Guangzhou 510180, Guangdong, China ; 2.Department of Hematology, Nanfang Hospital, Southern Medical University Guangzhou 510515, Guangdong, China)
Abstract:Objective To explore the relationship of cytokones associated with Th17 cells in serum and acute graft-versus-host disease from patients with hematologic diseases who were undergone al-logeneic hematopoietic stem cell transplantation. Methods In this study,78 patients with haemato-logical diseases were undergone allogeneic hematopoietic stem cell transplantation. Th17 cell-associ-ated cytokines in serum were examined by enzyme linked immunosorbent assay(ELISA)from pa-tients with acute graft-versus-host disease(aGVHD)(n=12),without aGVHD(n=14),and patients with aGVHD who were effectively treated(n=10). Healthy volunteers (n=10) were severed as control. Results ①The serum cytokine levels(pg/mL)of patients with aGVHD(n=12)were signifi-cantly higher compared with healthy control group(n=10)and non-aGVHD group(n=14)(P&lt;0. 05). On contrary,The TGF-β1 level(pg/mL)(1 156. 61 &#177; 458. 04) was significantly lower than the healthy control group(2 978. 34 &#177; 1 647. 71)and non-aGVHD group(2 541. 62 &#177; 1 805. 16)(P&lt;0. 05). IL-22:non-aGVHD group was significantly higher than healthy control group(22. 14&#177;2. 49, 19. 18&#177;1. 24)(P&lt;0. 05);IL-21,IL-22,IL-23 were higher than healthy control group(P&lt;0. 05), there was no statistical difference about other cytokines between healthy control group and non-aGVHD group(P&gt;0. 05).②After treatment,the cytokine levels above in 10 cases of effective treatment decreased to considerable extent ,and there was significant difference between before and after effective treatment(P &lt;0. 05),but the IL-22 showed no significant difference between before and after effective treatment (P&gt;0. 05). Conclusion Th17 cell-associated cytokines(IL-17, IL-23,IL-21,IFN-γ,TGF-β1)in serum are assocoated with pathogenesis,development and treat-ment efficacy of aGVHD,whereas acute GVHD is no relationship with IL-22 cencentration in serum.
Keywords:graft-versus-host disease  acute  cytokine  Th17 cell  regulatory T cell
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号